Executive summaries on hypertension I. Initial evaluation and nondrug therapies

Norman M Kaplan

Research output: Contribution to journalReview article

Abstract

As defined in the sixth report of the U.S. Joint National Committee (JNC-VI), additional risk factors beyond accurately measured blood pressure should be considered in making the decision to institute drug therapy for hypertension. Lifestyle modifications should be strongly advocated for all patients, and may safely be used alone in those who are at relatively low overall risk, even if the blood pressure is as high as 160/100 mmHg.

Original languageEnglish (US)
Pages (from-to)707-713
Number of pages7
JournalDrugs of Today
Volume33
Issue number10
StatePublished - Dec 1 1997

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Executive summaries on hypertension I. Initial evaluation and nondrug therapies'. Together they form a unique fingerprint.

Cite this